Related Experiment Video
Updated: May 3, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 5, 2010
Noncompliance and treatment failure in children with asthma
H Milgrom1, B Bender, L Ackerson
1Department of Pediatrics, National Jewish Center for Immunology and Respiratory Medicine, Denver, CO 80206, USA.
Insights
Children with asthma often overreport adherence to inhaled corticosteroids. Electronic monitoring revealed significantly lower actual use, with poor adherence linked to disease exacerbations, highlighting a need for better compliance assessment.
Area of Science:
- Pediatric Pulmonology
- Asthma Management
- Medication Adherence Research
Background:
- Asthma is a significant cause of childhood morbidity and mortality.
- Inhaled medications are increasingly relied upon for pediatric asthma treatment.
- Accurate data on children's adherence to inhaled therapies is crucial.
Purpose of the Study:
- To evaluate adherence rates of children with asthma to inhaled corticosteroid and beta-agonist regimens.
- To compare patient-reported adherence with electronically monitored adherence.
- To identify factors associated with non-adherence in pediatric asthma patients.
Main Methods:
- Utilized electronic metered-dose inhaler monitors and traditional diary cards for data collection.
- Included 24 children (8-12 years old) with asthma on both inhaled corticosteroids and beta-agonists.
- Monitored adherence over 13 weeks, correlating with disease exacerbations requiring oral corticosteroids.
Main Results:
- Patients reported 95.4% adherence to inhaled corticosteroids, while electronic monitors showed 58.4% actual use.
- Over 90% of patients exaggerated their adherence in diary entries.
- Lower adherence (13.7%) was observed in children experiencing exacerbations compared to those not (68.2%).
Conclusions:
- Electronic monitoring reveals significantly lower adherence to inhaled corticosteroids than patient diaries suggest.
- Poor adherence to inhaled corticosteroids is strongly associated with asthma exacerbations.
- Physicians should consider noncompliance when asthma control is suboptimal.
Background:
Accurate and reliable information about children's use of inhaled medications is needed because of the growing reliance on these drugs in the treatment of asthma and the excessive morbidity and mortality attributable to this disease.
Objective:
This study was designed to evaluate the adherence of children with asthma to regimens of inhaled corticosteroids and beta-agonists.
Methods:
Data collected electronically by metered-dose inhaler monitors were compared with data recorded by patients on traditional diary cards. A volunteer sample of 24 children, between 8 and 12 years old, who had asthma for which they were receiving both inhaled corticosteroids and beta-agonists, participated over a 13-week period. Each child was accompanied by a parent to all study visits. The main outcome measures were the use of medication as reported by diary card entries and recorded by electronic monitoring and disease exacerbation, as indicated by requirement for oral corticosteroids.
Results:
The median use of inhaled corticosteroids reported by patients on their diaries was 95.4%, whereas the median actual use was 58.4%. More than 90% of patients exaggerated their use of inhaled steroids, and diary entries of even the least compliant subjects reflected a high level of adherence. The children who experienced exacerbation of disease sufficient to require a burst of oral corticosteroids differed markedly from the others in their adherence to prescribed therapy as recorded by the electronic monitors. The median compliance with inhaled corticosteroids was 13.7% for those who experienced exacerbations and 68.2% for those who did not.
Conclusions:
Electronic monitoring demonstrated much lower adherence to prescribed therapy than was reported by patients on diary cards. Low rates of compliance with prescribed inhaled corticosteroids were associated with exacerbation of disease. Poor control of asthma should alert the physician to the possibility of noncompliance.
More Related Videos
07:28Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
04:16Inspiratory Muscle Training as an Adjunct to the Treatment of Weaning Failure in Critically Ill Patients: A Practical Guide
Published on: January 30, 2026
Related Concept Videos
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
COPD: Management Using Bronchodilators and Corticosteroids
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-IV: Nursing Management
First, in...
Asthma III: Clinical Manifestations